Share on StockTwits

Research analysts at Sterne Agee lifted their price objective on shares of PAREXEL International (NASDAQ:PRXL) from $36.00 to $42.00 in a report released on Friday. Sterne Agee’s target price would suggest a potential downside of 25.24% from the company’s current price.

A number of other analysts have also recently weighed in on PRXL. Analysts at Robert W. Baird raised their price target on shares of PAREXEL International from $64.00 to $66.00 in a research note on Thursday. They now have an “outperform” rating on the stock. Separately, analysts at Jefferies Group raised their price target on shares of PAREXEL International from $58.00 to $59.00 in a research note on Thursday. They now have a “hold” rating on the stock. Finally, analysts at KeyCorp initiated coverage on shares of PAREXEL International in a research note on Wednesday, July 2nd. They set a “hold” rating on the stock. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $56.63.

Shares of PAREXEL International (NASDAQ:PRXL) traded up 0.73% during mid-day trading on Friday, hitting $56.20. 776,376 shares of the company’s stock traded hands. PAREXEL International has a 52 week low of $37.53 and a 52 week high of $57.25. The stock’s 50-day moving average is $53.98 and its 200-day moving average is $51.74. The company has a market cap of $3.196 billion and a P/E ratio of 24.80.

PAREXEL International (NASDAQ:PRXL) last announced its earnings results on Thursday, August 7th. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.62 by $0.03. The company had revenue of $510.60 million for the quarter, compared to the consensus estimate of $508.99 million. During the same quarter in the previous year, the company posted $0.50 earnings per share. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. On average, analysts predict that PAREXEL International will post $2.68 earnings per share for the current fiscal year.

PAREXEL International Corporation (NASDAQ:PRXL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.